Company intelligence / Profile preview

Allez Health

San Diego, California, United Statesallezoutdoor.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Allez Health has developed a next-generation continuous glucose monitoring (CGM) biosensor with a focus on affordability, accuracy ("iCGM accuracy"), long wear time (15 days), real-time data integration, and eco-friendly design. The company has completed pivotal clinical studies involving over 120 users and more than 80 clinical studies overall with over 1,500 individuals. The sensor aims to disrupt the cost barrier in CGM while maintaining high performance. Regulatory filings are underway as of mid–2025.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health technologyBiosensor (Continuous glucose monitoring)
Industry: Physiological Monitoring

Partnerships

Osang Healthcare Co., Ltd. (strategic investor)

Beyond the preview

Go deeper on Allez Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allez Health.

Explore the full profile